PAA 2.50% 20.5¢ pharmaust limited

Ann: Human Cancer Trial - First Patient Initiates Treatment, page-4

  1. 10,237 Posts.
    lightbulb Created with Sketch. 244
    Yes lets see what PPL-1 can do do to humans
    -it works in animals,and the people in this trial have Failed all- standard of care-
    ,and so have nothing to loose,everythink to gain,by trialing ,and with 28 days of doses,we should get news flow going .

    well done mgt.,and yes genuine hiopes and prayers with the people taking part in trials
    PAA is following through with its ann. newsflow,looking at asx releases,its getting on with trials ,not slowing down,
    listening to the last interview with the ceo,theres a lot to like here.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
20.5¢
Change
0.005(2.50%)
Mkt cap ! $99.71M
Open High Low Value Volume
20.5¢ 20.5¢ 20.0¢ $66.86K 327.5K

Buyers (Bids)

No. Vol. Price($)
3 27750 20.0¢
 

Sellers (Offers)

Price($) Vol. No.
20.5¢ 84999 3
View Market Depth
Last trade - 14.42pm 27/09/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.